administrator

Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

The Latest From Jayson MacLean

Medexus has a 140 per cent upside, says Echelon

eCommerce Fintech nvei

Nuvei is one of my top picks, this investor says

Analysts Marketing sbio

Sabio wins another target raise from Paradigm

Analysts Software syz

Sylogist is now a double, says Echelon

Analysts Pharma and Biotech arch

Take a pass on Arch Biopartners, says Raymond James

Analysts Health care

Dialogue Health Technologies keeps Buy rating with Laurentian

Analysts Resource Tech hevi

Helium Evolution is a Buy, says Eight Capital

Analysts Cleantech arry

Buy Array Technologies on pullbacks, says Roth

Analysts Health well

WELL Health Technologies is a Top Pick for Haywood

Analysts Gaming Media pmkr

Playmaker Capital is heading higher, says Echelon

Analysts Cannabis hexo

HEXO is still a pass, says Roth Capital

Software csu

Constellation Software has more runway yet, this investor says

Analysts Software syz

Sylogist is a Buy, says Laurentian Bank

Analysts Resource Tech aqn

Algonquin Power is still a pass, says iA Capital

Analysts IT Telco cgy

Calian Group scores target lift from Echelon

Analysts Health care lspk thnk well

Four Canadian Health Tech stocks rated by Desjardins

Analysts Hardware IT Software sftc

Softchoice has a 70 per cent upside, says ATB

Analysts Software dcbo

Docebo is heading back to $90, says ATB

Analysts Health crrx

Lots of upside to CareRx, according to Desjardins

Analysts Media bbtv

BBTV keeps Buy rating with Eight Capital

Analysts Software bwlk

Boardwalktech has a 62.5 per cent upside, says Echelon

Analysts Health vmd

Viemed gets a target boost from Beacon

Analysts Health prof

Still more upside to Profound Medical, says Leede Jones Gable

Analysts Pharma and Biotech crdl

Cardiol Therapeutics has a huge upside, says Leede Jones Gable

Analysts fora

Vertical Scope keeps Buy rating with Eight Capital

Analysts Automotive Software einc

E Inc is still a pass, says Eight Capital

Analysts vol

Volatus has a 125 per cent upside, says Echelon

Cannabis

Cannabis stocks are going nowhere, this portfolio manager says

Airlines Analysts cjt

Cargojet is a Buy after quarterly earnings, says Beacon

Analysts Telco t

Telus is best-in-class among telcos, this Scotia manager says

Get Stock Picks from the Pros. In your Inbox.